Table 2.
A review of performed immunohistochemical examinations in CCOT and GCOC in the literature.
| Zhu et al. (2012) [19] | Li et al. (2011) [12] | Gong et al. (2009, 2006) [20, 21] | Motosugi et al. (2009) [4] | Roh et al. (2008) [13] | Geng et al. (2008) [22] | Kim et al. 2000 [23] | Folpe et al. (1998) [24] | Piattelli et al. (1998) [25] | |
|---|---|---|---|---|---|---|---|---|---|
| CCOT | |||||||||
| Ki-67 | W | W | W | W | S | ||||
| P53 | W | W | |||||||
| CK5 & CK14 | P | ||||||||
| CK18 | N | ||||||||
| TIMP-1 | W | ||||||||
| MMP-9 | W in T W in St W in G |
W in T W in St |
W | ||||||
| NF-kappaB | S in CT W in NT |
||||||||
| BCL2 | S | ||||||||
| GCOC | |||||||||
| Ki-67 | S | S | S | S | |||||
| P53 | S | P | |||||||
| CK5 & CK14 | P | ||||||||
| EMA & NSE | P | ||||||||
| CK18 | N | ||||||||
| TIMP-1 | S | ||||||||
| MMP-9 | W in T S in St W in G |
W in T S in St |
S | ||||||
| TRAP & VR | N in T P in G |
||||||||
| INVOLUCRN CK, BCLXL |
P in T N in G |
||||||||
| BCL2 | N in T N in G |
||||||||
| BAX | N in T P in G |
MMP: matrix metalloproteinase
TIMP: tissue inhibitor of metalloproteinase
VR: vitronectin receptor
TRAP: tartrate-resistant acid phosphatase
T: tumor
St: stroma
G: ghost cell
P: positive
N: negative
W: weak
S: strong
CT: cytoplasm of tumor cells
NT: nucleus of tumor cells.